got COVID-19 after getting the Moderna vaccine; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (got COVID-19 after getting the Moderna vaccine) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A, 048A21A, 939906 and 939906) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high, Thyroid disorder NOS, COPD, Cholesterol, Reflux esophagitis and Osteoporosis. Concomitant products included LISINOPRIL for Blood pressure high, BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT) for COPD, ROSUVASTATIN for Cardiovascular disorder, EZETIMIBE for Cholesterol, SALBUTAMOL SULFATE (ALBUTEROL [SALBUTAMOL SULFATE]) for Lung disorder, DENOSUMAB (PROLIA) for Osteoporosis, PANTOPRAZOLE for Reflux esophagitis, LEVOTHYROXINE for Thyroid disorder NOS, ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Jun-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In December 2021, the patient experienced COVID-19 (got COVID-19 after getting the Moderna vaccine). At the time of the report, COVID-19 (got COVID-19 after getting the Moderna vaccine) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2021, SARS-CoV-2 test: positive Positive.         Patient had taken medications for heart and lungs.  No other vaccines were given within 1 month prior to Moderna COVID-19 vaccine. The adverse event did not cause patient to seek medical care. No treatment medication was provided.  Company comment- This spontaneous case concerns a 67-year-old female patient with no relevant medical history, who experienced unexpected, non-serious adverse event of special interest Covid 19 (with a positive SARS-CoV-2 test) approximately 2 months after vaccination with a third dose of mRNA-1273. Inappropriate schedule of vaccine administration was noted in the case (40 days between dose 1 and 2). No further information was provided. The outcome of the events was reported as unknown. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2022-582490, MOD-2022-581890, MOD-2022-582490 (Patient Link).; Sender's Comments: This spontaneous case concerns a 67-year-old female patient with no relevant medical history, who experienced unexpected, non-serious adverse event of special interest Covid 19 (with a positive SARS-CoV-2 test) approximately 2 months after vaccination with a third dose of mRNA-1273. Inappropriate schedule of vaccine administration was noted in the case (40 days between dose 1 and 2). No further information was provided. The outcome of the events was reported as unknown. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.